Absorption Systems, a global leader in the science of translational medicine, pharmacokinetic testing of drugs, and safety testing of medical devices, announces that it has constructed a second facility in San Diego, CA. The expansion increases the company's west coast footprint by 60%, to a total of about 50,000 square feet. This expansion is driven by sustained demand for the company's contract services to pharmaceutical and biotechnology companies throughout the world. The new site was built to exacting specifications, to meet or exceed regulatory requirements for animal care and use while also accommodating cutting-edge in vivo and in vitro science.
The new facility features a digitally monitored, state-of-the-art vivarium, which meets U.S. and European Union requirements, and multiple procedure rooms to enable both routine and complex studies. Routine studies include preclinical pharmacokinetic profiling of novel and modified existing small molecule therapeutics and biologics administered via various dose routes. The more complex studies involve the use of surgically modified animals, immune-compromised animals, disease models for efficacy, and other specialized mechanistic models.
Increased capacity for rodent and large animal pharmacokinetics and toxicology studies, efficacy models, and a well-equipped formulations lab to support these studies are features of the new site. Additionally, in-life studies will be supported by a bioanalytical lab featuring sensitive, state-of-the-art mass spectrometers. Both the existing facility the new site are registered with the USDA and accredited by AAALAC.
Vatsala Naageshwaran, VP of Corporate Development and Site Head for the San Diego facility, highlights the value of this expansion, stating "What excites us the most about this expansion is that it gives us the ability to augment our portfolio of preclinical models for improved characterization of novel therapies, delivery technologies, and formulations. This site greatly increases our capacity and thereby our ability to support the needs of our clients."
About Absorption Systems
Absorption Systems, founded in 1996, assists pharmaceutical, biotechnology and medical device companies in identifying and overcoming ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) barriers in the development of drugs, biologics and medical devices. The company's mission is to continually develop innovative research tools that can be used to accurately predict human outcomes or to explain unanticipated human outcomes when they occur. IDAS2™, a novel in vitro test system for simultaneous screening of drug absorption and dissolution, exemplifies Absorption Systems' commitment to innovation and is soon to be an industry standard for formulation assessment. Absorption Systems, with facilities near Philadelphia, PA, in San Diego, CA, and in Panama, serves customers throughout the world. For information on the company's comprehensive contract services, applied research programs, and proprietary test systems, please visit www.absorption.com.